HeartLung.AI will be the only company at ESC Congress 2026 presenting this high number of accepted scientific studies. The achievement reflects the strength of the company’s research program and the ...

It’s going to be a busy 4 days in Paris, with 166 late-breaking studies and nearly 2,000 clinical cases to be presented.

Activating the GPR133 receptor with a small molecule can rebuild bone from within, offering a new direction for osteoporosis ...

A study published in Arteriosclerosis, Thrombosis, and Vascular Biology has identified Bmal1 as a potential key driver of ...

President Donald Trump’s tumbling approval ratings are raising the odds that the 2026 midterm elections will extend one of ...

In light of all of this, the cardiologist recommended 81 mg of aspirin nightly. Why is he recommending aspirin? It causes ...

The pattern of valvular heart disease in India is shifting. Degenerative tricuspid aortic stenosis now accounts for 58.1% of acquired isolated aortic stenosis (AS) cases (mean age 63.2 ± ...

I recently read in your column that you test your patient's magnesium levels when they have been on long-term proton-pump ...

Recent developments of interest in cardiovascular medicine ...

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Discovery Fund”. A copy ...

Alebund Pharma completes patient enrollment in global phase III pivotal multi-regional clinical trial of AP301 for hyperphosphatemia: Shanghai, China Thursday, May 7, 2026, 13:00 ...